CSI Market
Sign In | Register

Genmark Diagnostics Inc (GNMK) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access GNMK Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Genmark Diagnostics Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2020)
12 Months 		(Sep 30 2020) (Jun 30 2020) (Mar 31 2020) (Dec 31 2019)
Operating Activities
Income-18.64
Depreciation & amortization7.07
Amortization of Other Assets2.25
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.02
Inventories Decrease /-Increase-10.16
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation12.80
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total0.00
Impairment Of Intangible Assets Excluding Goodwill-
Increase Decrease In Operating Lease Right Of Use Asset And Lease Liability-
Income taxes0.36
Gain (Loss) on Sale of Equity Investments0.00
Accounts Receivable0.84
Increase (Decrease) in Accounts Payable5.22
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.86
Other Working Capital2.81
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.26
Discontinued operations0.00
Net Cash flow from Operating Activities6.13
Investing Activities
Capital Expenditures-17.78
Sale of Capital Items0.00
Short-term Investments Proceeds35.45
Payments to Acquire Marketable Securities-114.19
Real Estate Investments0.00
Proceeds From Sale Of Marketable Securities And Preferred Stock-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-96.51
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.10
Long-term debt - borrowings0.00
Long-term debt - repayments-0.06
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock87.73
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Transfer of Systems From To Property and Equipmentinto Inventory0.65
Property And Equipment Costs Incurred But Not Paid Included In Other Current Liabilities-
Intellectual Property Acquisition Included In Accrued Expenses-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities87.57
Effect of exchange rate on cash flow-0.10
Discontinued operations0.00
Free Cash Flow-11.64
Total Cash Flow-2.90
4 historic quarters locked

Sign in to unlock the full Genmark Diagnostics Inc cash flow history.

Sign In Create Free Account

About GNMK Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.